Use of intravenous valproate in a patient with neuroleptic malignant syndrome.
Tadke
Rahul R
RR
Suryavanshi
Praveen
P
D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001714:Bipolar Disorder / Q000188:drug therapy; D003402:Creatine Kinase / Q000097:blood; D003937:Diagnosis, Differential; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007262:Infusions, Intravenous; D007273:Injections, Intramuscular; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D014635:Valproic Acid / Q000008:administration & dosage*
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D014635:Valproic Acid; D003402:Creatine Kinase; D006220:Haloperidol